Form 8.3

Summary by AI BETAClose X

Qube Research & Technologies Limited disclosed an opening position in Tate & Lyle plc (29 1/6p ordinary) as at 10-11-2026: cash-settled derivatives referencing 7,248,364 shares (1.62%) and short positions of 559,312 shares (0.12%), giving a net economic long exposure of 1.50%; direct ownership, stock-settled derivatives and subscription rights are zero; multiple equity-swap transactions were recorded at c.560.00–562.00 GBp and no indemnities or arrangements were declared. Disclosure date 11-11-2026.

Disclaimer*

Companies

Tate & Lyle (TATE)
UK 100

Latest directors dealings